Taiwan FDA registration 143feab7076da86650ebee3e0ba400b8

Rapid pregnancy test reagent for the Laili people

TW: 萊禮伊人快速驗孕試劑

Taiwan·Risk Class 2·Dongyao Biotechnology Co., Ltd.; Laili Biomedical Technology Co., Ltd·Registered Apr 09, 2019 – Sep 28, 2025Expired

Registration details

Analysis ID: 143feab7076da86650ebee3e0ba400b8

Company information

Manufacturer: Dongyao Biotechnology Co., Ltd.; Laili Biomedical Technology Co., Ltd
Manufacturer Country: Taiwan, Province of China
Authorized Representative: R&R MEDICAL CORPORATION LTD.

Product details

Intended Use: Urine is tested qualitatively for human chorionic gonadotropin (HCG).
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1155 Human chorionic gonadotropin testing system
Import Information: Contract manufacturing;; Domestic

Dates and status

Registration Date: Apr 09, 2019
Expiry Date: Sep 28, 2025

About this record

Access comprehensive regulatory information for Rapid pregnancy test reagent for the Laili people in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 143feab7076da86650ebee3e0ba400b8 and manufactured by Dongyao Biotechnology Co., Ltd.; Laili Biomedical Technology Co., Ltd. The authorized representative in Taiwan is R&R MEDICAL CORPORATION LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.